Ӧzlem Türeci
9PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors.Oliver Bechter, Carmen Loquai, Stephane Champiat
|Jun 17, 2024
RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine-Induced Antitumor T-cell Immunity.Daniel Peters, Lena M Kranz, David Eisel
|Jan 06, 2023
Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer.Florian Lordick, Peter Thuss-Patience, Michael Bitzer
|Jun 02, 2022
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.Jasmin Quandt, Alexander Muik, Nadine Salisch
|Jan 18, 2022
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.Alexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch
|Dec 15, 2021
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.Miwa Haranaka, James Baber, Yoichiro Ogama
Pageof 2
Frequent Collaborators
8 joint publications
Ugur Sahin
3 joint publications
Ann-Kathrin Wallisch
3 joint publications
Alexander Muik
2 joint publications
Kena A Swanson
2 joint publications
Philip R Dormitzer
2 joint publications
Thomas Bukur
2 joint publications
Daniel Maurus
2 joint publications
Julia Mühl
2 joint publications
Sebastian Kreiter
2 joint publications
Lena M Kranz
